Back to Results
First PageMeta Content
T cells / Immunology / PD-1 / Trastuzumab / HER2/neu / CD25 / Natural killer cell / Immunotherapy / Antigen / Biology / Immune system / Anatomy


Extended Immunological Analysis of Two Phase 1 Clinical Trials of MVA-BN®-HER2 in HER-2 Overexpressing Metastatic Breast Cancer Patients Fatema Legrand1, Rachel Owen1, Michael Delacher1, Anh-Tuan Nguyen1, Ulf Reimer2,
Add to Reading List

Document Date: 2013-03-12 10:48:04

Open Document

File Size: 376,93 KB

Share Result on Facebook

City

Berlin / Baseline Luciferase / Mountain View / /

Company

IgG / JPT Peptide Technologies / Alain Delcayre1 1BN ImmunoTherapeutics Inc. / USA 2JPT Peptide Technologies GmbH / /

Country

Germany / /

/

Event

FDA Phase / /

IndustryTerm

microarray technology / /

MedicalCondition

cancer / tumors / breast cancer tumor / human tumor / metastatic breast cancer / universal tetanus / stable disease / breast cancer / /

MedicalTreatment

vaccination / chemotherapy / /

/

Product

Herceptin / RepliTope / BR-001 / /

ProvinceOrState

California / /

PublishedMedium

Baseline / /

Technology

RepliTope™ technology / BR-002 protocols / DNA Chip / Antibodies / chemotherapy / microarray technology / /

SocialTag